PDCD1 and neoplasm: Zhang’s team reported that an engineered cell nano vesicle (NVs) presents PD-1 receptors on its membrane, breaking the PD-1/PD-L1 immunosuppressive axis and enhancing anti-tumor T cell immune responses [187].